Acadia Pharmaceuticals reported $444.8M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 444.8M 96.1M
ALKERMES ALKS:US $ 1075.39M 37.19M
Alnylam Pharmaceuticals ALNY:US $ 401.17M 187.04M
Aptinyx Inc APTX:US $ 77.48M 17.27M
Biogen BIIB:US $ 11242.3M 346.1M
Biomarin Pharmaceutical BMRN:US $ 4391.31M 120.58M
Bristol Myers Squibb BMY:US $ 31580M 4366M
Cara Therapeutics CARA:US $ 204.11M 23.41M
Corcept Therapeutics CORT:US $ 407.81M 32.01M
Cytokinetics CYTK:US $ 116.26M 127.6M
Eisai 4523:JP Y 748822M 14034M
Eli Lilly And LLY:US $ 9330.8M 351.6M
Intercept Pharmaceuticals ICPT:US $ -371.76M 187.8M
Intra Cellular Therapies ITCI:US $ 792.75M 374.86M
Johnson & Johnson JNJ:US $ 74709M 686M
Marinus Pharmaceuticals MRNS:US $ 40.4M 13.08M
Moderna Inc MRNA:US 17.08B 2.93B
Neurocrine Biosciences NBIX:US $ 1391.1M 17.1M
Pfizer PFE:US $ 82424M 5224M
Prothena PRTA:US $ 438.89M 27.16M
Ptc Therapeutics PTCT:US $ -90.58M 92.02M
Sarepta Therapeutics SRPT:US $ 856.89M 71.12M
Seattle Genetics SGEN:US $ 2998.47M 66.67M
Ultragenyx Pharmaceutical RARE:US $ 796.42M 126.14M
Vanda Pharmaceuticals VNDA:US $ 502.12M 2.8M
Vertex Pharmaceuticals VRTX:US $ 10907M 807M
YTE INCY:US $ 3863.07M 93.07M